Middle East Active Pharmaceutical Ingredients (API) Market, valued at USD 7.82 billion in 2024, is projected to reach USD 12.46 billion by 2032, growing at a CAGR of 5.9% during the forecast period. Market growth is fueled by the rising burden of chronic diseases, increasing demand for generic drugs, expansion of regional pharmaceutical manufacturing capabilities, and...